Wire · founder news, decoded · opportunities
AG Paxton Secures Settlement With Genetic Testing Company Over Privacy Concerns
Texas AG Paxton secured a settlement with 23andMe over a 2023 data breach affecting 6.9 million customers, including Texans. The settlement mandates enhanced data security standards, independent oversight, and prevents the sale of customer genetic data without explicit consent.
This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.
The Wire takeaway
If you're building a genetic testing or consumer health data platform, you now face a multi-state enforcement template: explicit consent for any data transfer, independent security oversight, and state liability for breaches. The 23andMe precedent means your data handling practices will be tested in bankruptcy court and across state AGs simultaneously.
Read the full story at texasscorecard.com →
Topics: Digital Health · genetic-privacy · data-breach-liability · consumer-consent · state-enforcement · healthtech-regulation